IRIDEX Corp
NASDAQ:IRIX
IRIDEX Corp
Revenue
IRIDEX Corp
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
IRIDEX Corp
NASDAQ:IRIX
|
Revenue
$51.9m
|
CAGR 3-Years
13%
|
CAGR 5-Years
4%
|
CAGR 10-Years
3%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Revenue
$19.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
9%
|
|
Boston Scientific Corp
NYSE:BSX
|
Revenue
$14.2B
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
Stryker Corp
NYSE:SYK
|
Revenue
$20.5B
|
CAGR 3-Years
13%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
Abbott Laboratories
NYSE:ABT
|
Revenue
$40.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Revenue
$7.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
14%
|
CAGR 10-Years
13%
|
IRIDEX Corp
Revenue Breakdown
Breakdown by Geography
IRIDEX Corp
Total Revenue:
51.9m
USD
|
United States:
26.1m
USD
|
Europe, Middle East And Africa:
13.5m
USD
|
Asia Pacific:
10.2m
USD
|
Americas Excluding U S:
2.1m
USD
|
Breakdown by Segments
IRIDEX Corp
Total Revenue:
51.9m
USD
|
Retina:
29.4m
USD
|
Cyclo G Six:
13.5m
USD
|
Product And Service, Other:
9m
USD
|
See Also
What is IRIDEX Corp's Revenue?
Revenue
51.9m
USD
Based on the financial report for Dec 30, 2023, IRIDEX Corp's Revenue amounts to 51.9m USD.
What is IRIDEX Corp's Revenue growth rate?
Revenue CAGR 10Y
3%
Over the last year, the Revenue growth was -9%. The average annual Revenue growth rates for IRIDEX Corp have been 13% over the past three years , 4% over the past five years , and 3% over the past ten years .